Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 10, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | $320.00 | B | $36.75 | 770.66% | 1,032.26x | 47.77x | 13.10x | 180.75x | 3.36x | $221.36M | 0.53% | $233.89M | 1.78 | $44.00B | 289.61 |
| THC | TENET HEALTHCARE CORP | A | $192.96 | B | $140.77 | 37.08% | 13.02x | 11.62x | 0.81x | 4.22x | 1.27x | $1.54B | 9.05% | $4.01B | 45.64 | $27.17B | 7.81 |
| NBIX | NEUROCRINE BIOSCIENCES INC | A | $139.56 | B | $94.42 | 47.81% | 32.38x | 19.05x | 5.17x | 4.63x | 0.74x | $593.10M | 4.28% | $3.00B | 30.22 | $14.00B | 20.62 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | $165.00 | A | N/A | N/A | -27.55x | 7.13x | 2.41x | 2.53x | N/A | $1.34B | 13.35% | $3.96B | 65.23 | $14.11B | 77.28 |
| VISN | VISTANCE NETWORKS INC | A | $19.43 | A | N/A | N/A | 4.74x | 12.53x | 0.81x | -1.84x | N/A | $277.70M | 6.45% | -$2.34B | -10.59 | $10.85B | 6.40 |
| INDV | INDIVIOR PLC | A | $33.86 | B | $26.76 | 26.55% | 25.85x | 11.24x | 3.58x | -20.42x | 0.65x | $78.00M | 1.84% | -$207.00M | -1.66 | $4.14B | 13.10 |
| RSI | RUSH STREET INTERACTIVE INC | A | $17.70 | C | $8.24 | 114.70% | 53.64x | 32.56x | 1.60x | 30.51x | 1.02x | $91.18M | 5.36% | $133.08M | 1.38 | $3.78B | -114.49 |
| VCYT | VERACYTE INC | A | $36.73 | C | $12.44 | 195.19% | 94.18x | 32.50x | 5.84x | 2.31x | 1.32x | $98.21M | 3.40% | $1.26B | 15.98 | $2.63B | 46.09 |
| HCI | HCI GROUP INC | A | $160.73 | C | N/A | N/A | 9.31x | 9.76x | 2.55x | 2.53x | N/A | $404.26M | 19.41% | $821.78M | 63.41 | $1.16B | 3.86 |
| HLMN | HILLMAN SOLUTIONS CORP | A | $10.25 | C | $5.71 | 79.64% | 51.25x | 16.87x | 1.32x | 1.64x | 0.83x | $41.07M | 2.03% | $1.23B | 6.22 | $2.77B | 11.11 |
| FIVN | FIVE9 INC | A | $17.04 | A | $18.93 | -9.99% | 40.57x | 5.25x | 1.17x | 1.72x | 0.38x | $127.31M | 9.64% | $775.29M | 10.00 | $1.94B | 15.16 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | A | $46.62 | B | $107.48 | -56.63% | 42.00x | 10.33x | 1.70x | 2.92x | 0.17x | $101.20M | 7.92% | $423.10M | 15.44 | $1.38B | 11.57 |
| TBLA | TABOOLACOM LTD | A | $3.51 | C | $2.83 | 23.82% | 43.88x | 6.97x | 0.56x | 1.11x | 0.54x | $168.43M | 15.95% | $911.46M | 3.03 | $1.06B | 7.76 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | A | $30.56 | B | N/A | N/A | 6.98x | 9.06x | 0.54x | 1.73x | N/A | $249.86M | 29.36% | $495.04M | 17.78 | $490.24M | 2.81 |
| NRDS | NERDWALLET INC | A | $10.26 | A | $9.92 | 3.41% | 10.58x | 10.80x | 0.98x | 1.85x | 0.87x | $84.20M | 10.84% | $402.40M | 5.32 | $625.44M | 6.38 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | A | $18.90 | B | N/A | N/A | N/A | 0.39x | 0.92x | 10.05x | N/A | $88.20M | 12.51% | $70.18M | 1.88 | $969.78M | 6.68 |
| LE | LANDS' END INC | A | $18.60 | C | $15.92 | 16.81% | 50.27x | 22.29x | 0.43x | 2.46x | 0.49x | $13.36M | 2.35% | $231.02M | 7.57 | $855.99M | 9.86 |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | $3.83 | C | N/A | N/A | -31.92x | 25.90x | 1.04x | 1.91x | N/A | -$51.65M | -10.63% | $255.13M | 2.01 | $462.51M | 25.65 |
| LTRX | LANTRONIX INC | A | $6.32 | C | N/A | N/A | -27.48x | 32.61x | 2.14x | 3.37x | N/A | $9.64M | 3.86% | $74.42M | 1.88 | $237.57M | -50.14 |
| ELMD | ELECTROMED INC | A | $27.61 | C | $9.28 | 197.39% | 28.46x | 25.53x | 3.47x | 5.15x | 2.73x | $8.78M | 3.82% | $44.75M | 5.38 | $216.17M | 17.94 |
| INFU | INFUSYSTEM HOLDINGS INC | A | $7.66 | C | $4.11 | 86.52% | 29.46x | 18.26x | 1.11x | 2.81x | 1.08x | $18.76M | 12.00% | $55.47M | 2.72 | $179.51M | 7.43 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.